Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Interest & Investment Income (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Interest & Investment Income for 3 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 46.62% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $6.0 million, up 11.4%, while the annual FY2025 figure was $6.0 million, 11.4% up from the prior year.
  • Interest & Investment Income hit $1.2 million in Q4 2025 for Artiva Biotherapeutics, down from $1.4 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $2.2 million in Q4 2024 and bottomed at $418000.0 in Q3 2023.
  • Average Interest & Investment Income over 3 years is $1.2 million, with a median of $1.2 million recorded in 2025.
  • Year-over-year, Interest & Investment Income surged 341.63% in 2024 and then plummeted 46.62% in 2025.
  • Artiva Biotherapeutics' Interest & Investment Income stood at $583000.0 in 2023, then soared by 273.41% to $2.2 million in 2024, then tumbled by 46.62% to $1.2 million in 2025.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $1.2 million, $1.4 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.